STAT December 4, 2023
E. Anders Kolb

The medical community today faces a deceptively simple question: How quickly should we act when a child’s life is on the line? I’m a pediatric oncologist, so my answer won’t surprise you — I think we should act immediately. But a new Food and Drug Administration policy could delay things for children who need treatment now.

Many childhood cancers are still treated with intensive chemotherapies developed decades ago that leave virtually all survivors with severe or life-threatening conditions such as hearing loss, heart disease, or secondary cancers later in life. This is the unavoidable nature of these old therapies, and it’s been one of the defining paradoxes of my 20-year career in pediatric oncology: The very treatments I give children...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Provider
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article